On the basis of these results, FBP1 appears to halt ovarian cancer cell proliferation, invasion, and migration, possibly by suppressing the expression of MMP3, and Bcl-2, and stimulating the expression of E-cadherin, which was consistent with the results of Zang et al. [19] in prostate cancer. The gene discussed is FBP1; the disease is prostate carcinoma.